Stemtech Corporation

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Stemtech Corp. engages in the development of nutritional supplements. It offers RCM System, stemrelease3, StemFlo, MigraStem, Collet One, OraStem, and OraStem 5-Pack. It operates through the following geographical segments: North America, Latin America, and Asia. The North America segment refers to its subsidiaries in United States and Canada. The Latin America segment includes subsidiaries in Mexico and Ecuador. The Asia segment relates to its subsidiaries in Malaysia and Taiwan. The company was founded on September 4, 2009 and is headquartered in Naples, FL.

Stemtech Corporation Announces Regional Business Academies in Mexico, US and Taiwan for 2023 MIRAMAR, FL / ACCESSWIRE / March 3, 2023 / STEMTECH CORPORATION (OTCQB:STEK) announces Business Academies for their Independent Business Partners (IBPs) will be conducted in Mexico in May, the United States in June and Taiwan in October. John W. Meyer, President and Chief Operating Officer, says "I am excited that Stemtech is once again conducting important Business Academies, filled with training opportunities for our IBPs.

Stemtech Announces Key Leadership Training for Independent Business Partners

With the addition of these two great products, we are fulfilling our strategic objective of the Stemtech 360 program in Taiwan MIRAMAR, FL / ACCESSWIRE / February 16, 2023 / STEMTECH CORPORATION (OTCQB:STEK) John W. Meyer, President and COO of Stemtech, says, "Stemtech Taiwan Holding, Taiwan Branch, recently launched two new products: Cellect One™ Skin Tightening and Repairing Serum, and OraStem® Toothpaste.

Stemtech Taiwan Launches Two New Products

Growing In Excess of over 10 percent in January over December 2022 MIRAMAR, FL / ACCESSWIRE / February 7, 2023 / STEMTECH CORPORATION - (OTCQB:STEK) John W. Meyer, President and COO of Stemtech, is "excited to announce that the number of new IBPs increased in January over December 2022 by over 10 percent.

Stemtech Announces Double Digit Growth, Moving It up Ranks in Global MLM Companies

Registration process for all products begins, preparing Stemtech to launch Stemtech Colombia MIRAMAR, FL / ACCESSWIRE / February 2, 2023 / STEMTECH CORPORATION (OTCQB:STEK) President and Chief Operating Officer, John W. Meyer, says "Stemtech has started working to launch Stemtech Colombia with our country offices intended to be located in Bogota.

Stemtech Announces Additional Expansion of International Markets

MIRAMAR, FL / ACCESSWIRE / January 27, 2023 / STEMTECH CORPORATION - (OTCQB:STEK) today announced the appointment of Mr. Claude Ayache as Vice President of Finance for Stemtech HealthSciences Corp, the US subsidiary.

Stemtech Corporation Appointment of Claude Ayache to Vice President Finance for Stemtech Healthsciences Corp (USA) Division

Moving up from 159th to 11th in ranking Substantiates our Aggressive growth and Market Presence MIRAMAR, FL / ACCESSWIRE / January 23, 2023 / Stemtech Corporation (OTCQB:STEK) today announced Soaring Momentum as published by independent network marketing industry publication " Business For Home ". President and Chief Operating Officer, John W.

Stemtech Corporation Now Ranked 11th in Momentum Out of Over 700 Global MLM Companies

MIRAMAR, FL / ACCESSWIRE / January 18, 2023 / STEMTECH CORPORATION - (OTCQB:STEK) today announced VISION 2023 concerning the exciting developments planned for the new year. President and Chief Operating Officer, John W.

Stemtech Corporation Vision 2023: Anticipates Growth Rate in 2023 Will Exceed 2022

MIRAMAR, FL / ACCESSWIRE / January 12, 2023 /STEMTECH CORPORATION - (OTCQB:STEK) today announced the release of their newly enhanced AdvanceOffice mobile app. Stemtech Vice President Global Performance, Sandra Kazickaite, says "I am excited to announce that Stemtech has put into production an enhanced version of our Mobile App, AdvanceOffice.

Stemtech Corporation Announces AdvanceOffice Business Analytics Mobile App Enhancement Release

MIRAMAR, FL / ACCESSWIRE / January 10, 2023 / STEMTECH CORPORATION - (OTCQB:STEK) today announced the appointment of Margie and Mike Mares of Stemtech Mexico to Stemtech's Field Advisory Board (FAB). Stemtech President & Chief Operating Officer, John W.

Stemtech Corporation Announces Margie and Mike Mares Appointment to Field Advisory Board

MIRAMAR, FL / ACCESSWIRE / December 27, 2022 / STEMTECH CORPORATION, (OTCQB:STEK) today announced that Stemtech's Taiwan Branch was honored by the Taiwan government agency which monitors the MLM businesses in Taiwan. Congratulations!

Stemtech Taiwan Branch Receives Taiwan Government Award

MIRAMAR, FL / ACCESSWIRE / December 22, 2022 / Stemtech Corporation (OTCQB:STEK) today announced that Life Factor Research, the Research and Development Division of Stemtech, has acquired its first contract to produce a while label product for a new client. Stemtech President & COO, John W.

Stemtech Cororation Announces Life Factor Research Obtains First Production Contract With New Customer

MIRAMAR, FL / ACCESSWIRE / December 15, 2022 / Stemtech Corporation ("Stemtech") (OTCQB:STEK), an innovative stemceutical™ company and the pioneer in the field of stem cell nutrition, today announced that the Leadership Event held at the Dreams Playa Mujeres Resort in Cancun, Mexico was a huge success. Stemtech Corporation President and Chief Operating Officer, John W.

Stemtech Corporation Heralds Cancun Leadership Event A Huge Success

MIRAMAR, FL / ACCESSWIRE / December 6, 2022 / Stemtech Corporation ("Stemtech") (OTCQB:STEK), an innovative stemceutical™ company and the pioneer in the field of stem cell nutrition, today announced the introduction of their new CellectOne™ innovative and cutting-edge Skincare line, with the first product being the Rapid Renew Stem Cell Peptide Night Cream. Stemtech Corporation President and Chief Operating Officer, John W.

Stemtech Corporation Announces Introduction of Cellectone(TM) Rapid Renew Stem Cell Peptide Night Cream

MIRAMAR, FL / ACCESSWIRE / December 6, 2022 / Stemtech Corporation ("Stemtech") (OTCQB:STEK), an innovative stemceutical™ company and the pioneer in the field of stem cell nutrition, today announced the promotion of Alejandro Carrillo. He is currently Stemtech's Managing Director of Latin Markets and is now advancing to the position of Vice President Global Sales.

Stemtech Corporation Announces Promotion of Alejandro Carrillo to Vice President Global Sales

MIRAMAR, FL / ACCESSWIRE / December 5, 2022 / STEMTECH CORPORATION (OTCQB:STEK) today announces that Darryl V. Green, Board Director, Investor and Advisor, will be participating at the RHK Capital Disruptive Growth Conference in New York City.

Stemtech Corporation to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 in New York City

MIRAMAR, FL / ACCESSWIRE / November 14, 2022 / Stemtech Corporation ("Stemtech") (OTCQB:STEK), an innovative stemceutical™ company and the pioneer in the field of stem cell nutrition, today announced that it will be releasing an enhanced version of their Stemtech AdvanceOffice mobile app. Stemtech Corporation President and Chief Operating Officer John W.

Stemtech Announces Imminent Release Of Innovative AdvanceOffice Mobile App

MIRAMAR, FL, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative stemceutical™ company and a pioneer in the field of stem cell nutrition, today announced that it has finalized its acquisition agreement with Life Factor Research, a leading manufacturer in the nutraceutical world.

STEMTECH CORPORATION ANNOUNCES LIFE FACTOR RESEARCH BECOMES PART OF STEMTECH

MIRAMAR, FL, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative stemceuticals™ company and a pioneer in the field of stem cell nutrition, today announced creation of new Board of Directors for their Stemtech Malaysia Sdn. Bhd.

STEMTECH CORPORATION ANNOUNCES NEW BOARD OF DIRECTORS FOR STEMTECH MALAYSIA SDN. BHD.

MIRAMAR, FL, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today that it was invited to present at the Roth Capital Healthcare Opportunities Conference in New York City on October 6.

STEMTECH CORPORATION INVITED TO PRESENT AT ROTH CAPITAL HEALTHCARE OPPORTUNITIES CONFERENCE IN NEW YORK CITY

MIRAMAR, FL, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced creation of new stem cell skincare products.

STEMTECH CORPORATION ANNOUNCES THE INTRODUCTION OF A NEW STEM CELL SKINCARE PRODUCT LINE

NEW YORK, NY / ACCESSWIRE / September 19, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Stemtech Corporation. Mark had the pleasure of recently conducting the Interview with Charles Arnold, Chief Executive Officer of Stemtech Corporation (OTCQB:STEK).

Traders News Source Senior Editor, Mark Roberts Interviews Charles Arnold, CEO Stemtech Corporation

Verb Technology Company Inc

MIRAMAR, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the Go-Live date of their Stemtech Advance Office based on the VERB Technology Company, Inc. (NASDAQ: VERB) system.

Stemtech Corporation Announces Go Live of Stemtech Advance Office Based on VERB Technology Monday Sep 19

MIRAMAR, FL, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the Go-Live date of their Stemtech Advance Office based on the VERB Technology Company, Inc. (NASDAQ: VERB) system.

STEMTECH CORPORATION ANNOUNCES GO LIVE OF STEMTECH ADVANCE OFFICE BASED ON VERB TECHNOLOGY MONDAY SEP 19!

MIRAMAR, FL, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that Professor Dr. Bankole Johnson joins the Stemtech Corporation Life Sciences Advisory Board (LSAB).

STEMTECH CORPORATION ANNOUNCES PROFESSOR DR. BANKOLE JOHNSON JOINS THEIR LIFE SCIENCES ADVISORY BOARD

MIRAMAR, FL, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that it has issued a Letter of Intent to acquire Life Factor Research , a scientific research and development company.

News for Stemtech Corporation Stock (STEK)